SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-024524
Filing Date
2022-05-06
Accepted
2022-05-06 16:05:49
Documents
15
Period of Report
2022-05-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FILING ea159481-8k_citius.htm   iXBRL 8-K 26788
2 PRESS RELEASE DATED MAY 6, 2022. ea159481ex99-1_citius.htm EX-99.1 11763
7 GRAPHIC image_001.jpg GRAPHIC 4477
  Complete submission text file 0001213900-22-024524.txt   265552

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ctxr-20220506.xsd EX-101.SCH 3663
4 XBRL DEFINITION FILE ctxr-20220506_def.xml EX-101.DEF 26560
5 XBRL LABEL FILE ctxr-20220506_lab.xml EX-101.LAB 36574
6 XBRL PRESENTATION FILE ctxr-20220506_pre.xml EX-101.PRE 25184
9 EXTRACTED XBRL INSTANCE DOCUMENT ea159481-8k_citius_htm.xml XML 5339
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 22901027
SIC: 2834 Pharmaceutical Preparations